ADGRE2
NM_013447.4:p.L160V
Handoko et al.
Cancers, 2025
Guo R et al.
Scientific Reports, 2025
Valentine H et al.
Cancer Research Communications, 2022
Raaijmakers MI et al.
Oncotarget, 2016